These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12778482)

  • 1. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms.
    Nicoll G; Avril T; Lock K; Furukawa K; Bovin N; Crocker PR
    Eur J Immunol; 2003 Jun; 33(6):1642-8. PubMed ID: 12778482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
    Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
    J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.
    Kawasaki Y; Ito A; Withers DA; Taima T; Kakoi N; Saito S; Arai Y
    Glycobiology; 2010 Nov; 20(11):1373-9. PubMed ID: 20663960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of polysialylated CD56 on natural killer cell cytotoxicity.
    Moebius JM; Widera D; Schmitz J; Kaltschmidt C; Piechaczek C
    BMC Immunol; 2007 Aug; 8():13. PubMed ID: 17683591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
    Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR
    J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ganglioside GD3 in HeLa cells might influence the cytotoxic abilities of NK cells.
    Lee WC; Lee WL; Shyong WY; Yang LW; Ko MC; Yeh CC; Hsieh SL; Wang PH
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):199-205. PubMed ID: 22795094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression.
    Zeng G; Li DD; Gao L; Birklé S; Bieberich E; Tokuda A; Yu RK
    Biochemistry; 1999 Jul; 38(27):8762-9. PubMed ID: 10393551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-specific expression of Siglec-6 in the placenta.
    Brinkman-Van der Linden EC; Hurtado-Ziola N; Hayakawa T; Wiggleton L; Benirschke K; Varki A; Varki N
    Glycobiology; 2007 Sep; 17(9):922-31. PubMed ID: 17580316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.
    Hashimoto N; Ito S; Tsuchida A; Bhuiyan RH; Okajima T; Yamamoto A; Furukawa K; Ohmi Y; Furukawa K
    J Biol Chem; 2019 Jul; 294(28):10833-10845. PubMed ID: 31138648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
    Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
    J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells.
    Bergelson LD; Dyatlovitskaya EV; Klyuchareva TE; Kryukova EV; Lemenovskaya AF; Matveeva VA; Sinitsyna EV
    Eur J Immunol; 1989 Nov; 19(11):1979-83. PubMed ID: 2598999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
    Helfand SC; Dickerson EB; Munson KL; Padilla ML
    Cancer Res; 1999 Jul; 59(13):3119-27. PubMed ID: 10397254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new sialic acid binding region that regulates Siglec-7.
    Yamakawa N; Yasuda Y; Yoshimura A; Goshima A; Crocker PR; Vergoten G; Nishiura Y; Takahashi T; Hanashima S; Matsumoto K; Yamaguchi Y; Tanaka H; Kitajima K; Sato C
    Sci Rep; 2020 May; 10(1):8647. PubMed ID: 32457377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside binding pattern of CD33-related siglecs.
    Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
    Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
    Ikehara Y; Ikehara SK; Paulson JC
    J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
    Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
    Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers.
    Miyazaki K; Ohmori K; Izawa M; Koike T; Kumamoto K; Furukawa K; Ando T; Kiso M; Yamaji T; Hashimoto Y; Suzuki A; Yoshida A; Takeuchi M; Kannagi R
    Cancer Res; 2004 Jul; 64(13):4498-505. PubMed ID: 15231659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Synthesis and Evaluation of a Disialic Acid-Containing Dextran Polymer as an Inhibitor for the Interaction between Siglec 7 and Its Ligand.
    Yamaguchi S; Yoshimura A; Yasuda Y; Mori A; Tanaka H; Takahashi T; Kitajima K; Sato C
    Chembiochem; 2017 Jul; 18(13):1194-1203. PubMed ID: 28374980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.